American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call on March 31, 2026, at 12:00 PM ET to discuss its fourth quarter and full year 2025 financial results. The earnings press release will be issued before the market opens on the same day, offering stakeholders a comprehensive view of the company's financial health and operational achievements over the past year.
The conference call is a key event for investors and industry analysts, as it provides an opportunity to hear directly from management about the factors driving the company's performance. American Shared Hospital Services operates through equipment leasing and direct patient care services, focusing on advanced technologies such as Gamma Knife and proton therapy. The company's results are closely watched given the growing demand for non-invasive cancer treatments and the expansion of radiation therapy services across North and South America.
To participate in the call, domestic callers can dial 1-844-413-3972 and international callers can dial 1-412-317-5776 at least ten minutes before the start. A simultaneous webcast will be accessible via the company's website at www.ashs.com or directly through this link. A replay will be available from 1-855-669-9658 or 1-412-317-0088 (access code 6331493) through April 7, 2026, and on the company's website.
The announcement comes at a time when the healthcare industry is increasingly focused on cancer care innovations. American Shared Hospital Services' turnkey solutions help health systems and cancer centers develop and grow their service lines, sharing capital investment and profitability based on ownership interests. This model aligns the company's success with that of its partners, potentially mitigating risks associated with technology adoption and reimbursement changes.
Investors will be particularly attentive to updates on the company's Gamma Knife and proton therapy businesses, as well as any commentary on reimbursement trends from the Centers for Medicare & Medicaid Services (CMS). The company's forward-looking statements in the press release highlight risks including market conditions, variability of financial results, and the timing of new projects. These factors underscore the importance of the conference call for assessing the company's near-term outlook.
The financial results and conference call represent a critical moment for American Shared Hospital Services to demonstrate its operational resilience and growth trajectory in the competitive cancer treatment market. As the company continues to expand its presence and integrate acquired businesses, the insights shared on March 31 will be instrumental for stakeholders making informed decisions.
